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ABSTRACT 
A 55-year-old male patient presented with an acute myocardial infarction. A sirolimus-eluting stent (SES) was implant-
ed in the proximal left anterior descending artery (LAD). Eight months later, there was a newly developed distal LAD 
lesion. An additional SES was implanted. Twenty-eight months after the index procedure of primary coronary inter-
vention, the electrocardiogram showed ST elevation in the precordial leads and an emergency coronary angiogram show- 
ed diffuse stent thrombosis (ST) in the proximal LAD. Thirty-four months after the index procedure, coronary angio-
graphy showed a large peri-stent coronary aneurysm in the proximal LAD and focal in-stent restenosis (ISR) at the 
proximal edge of the distal LAD stent. On fluoroscopy, a fracture was noted in the middle part of the distal SES. A zo-
tarolimus-eluting stent (ZES) was deployed and overlapped the restenosis and fracture sites. Forty months after the in-
dex procedure, there were no changes in the size of the aneurysm or in the other stent complications including the frac-
ture and restenosis. At present, the patient has remained asymptomatic for eight months. (Korean Circ J 2009;39:439-442) 
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Introduction 
 
Coronary artery stents significantly reduce the risk of 
restenosis when compared to balloon angioplasty. Re-
cently, drug-eluting stents (DES) have been shown to 
reduce neointimal hyperplasia more effectively as well as 
the need for repeat revascularization.
1)2) However, there 
are a variety of stent-related complications that occur 
after percutaneous coronary intervention. Herein we re-
port a case with a number of complications occurring in 
one patient after sirolimus-eluting stent (SES, Cypher; 
Cordis, Miami Lakes, FL, USA) deployment including 
very late stent thrombosis (VLST), stent fracture, in-
stent restenosis (ISR), and a peri-stent aneurysm. 
Case 
 
  A   5 5 -year-old male patient presented with a myocar-
dial infarction associated with acute anterior ST-eleva-
tion. He had a history of diabetes and hypertension. The 
echocardiogram revealed a left ventricular ejection frac-
tion of 36% with abnormal wall motion in the left an-
terior descending artery (LAD) territory before primary 
coronary angiography in the emergency room. Emergen-
cy coronary angiography showed total occlusion of the 
proximal portion of the LAD. A SES 3.5×23 mm was 
implanted in the proximal LAD. Eight months later, 
follow-up coronary angiography showed a patent LAD 
stent, and a newly developed distal LAD lesion. An ad-
ditional SES 3.0×23 mm was implanted. Despite con-
tinuous dual antiplatelet medication with aspirin and 
clopidogrel, severe chest pain developed twenty-eight 
months after the index procedure. The electrocardio-
gram showed ST elevation in the precordial leads and an 
emergency coronary angiogram was obtained. The an-
giogram showed diffuse stent thrombosis (ST) in the 
proximal LAD (Fig. 1A). At first, the lesion was dilated 
with a Ryujin (Terumo, Tokyo, Japan) balloon 2.5×23 
mm at 10 atm (Fig. 1B). The intravascular ultrasound 
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(IVUS, Galaxy
TM; Boston Scientific, Reading, PA, USA) 
study showed late stent malapposition (LSM) in the pro-
ximal LAD (Fig. 1C). The patient was treated with hepa-
rin and abciximab without the need for additional pro-
cedures. Repeat angiography showed that the thrombus 
was nearly resolved five days later (Fig. 1D). Thirtyfour 
months after the index procedure, a fifth follow-up co-
ronary angiogram was obtained. The results showed a 
large peri-stent coronary aneurysm in the proximal LAD 
(Fig. 2A). The IVUS revealed positive remodeling and 
peri-stent aneurysm formation in the proximal LAD (Fig. 
2B). There was a focal ISR at the proximal edge of the 
distal LAD stent (Fig. 3A). A fracture was noted in the 
middle part of the distal SES with fluoroscopy (Fig. 3B). 
A 64-slice multidetector computed tomogram (MDCT, 
Aquilion; Toshiba Medical Systems, Japan) demonstrated 
a coronary artery stent aneurysm and fracture of the 
stent (Fig. 4A and B). A zotarolimus-eluting stent 3.0×
30 mm (ZES, Endeavor; Medtronic Vascular, Santa Rosa, 
CA, USA) was deployed and overlapped the restenosis 
and fracture sites. Forty months after the index proce-
dure, the last coronary angiogram was obtained. There 
Fig. 1. Coronary angiography shows a stent thrombosis in the proximal left anterior descending artery (arrow) (A), post-balloon angioplasty
(B). An intravascular ultrasound shows late stent malapposition (*) (C). Angiography after five days reveals restoration of the normal blood
flow (D). 
A  B
C  D
Fig. 2. Follow-up angiography reveals a large proximal left anterior
descending artery aneurysm (arrow) (A) and an intravascular ul-
trasound shows malapposition of the stent (B). 
A  B  
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were no changes in the size of the aneurysm or in the 
other stent complications including the fracture and re-
stenosis. At present, triple antiplatelet therapy has been 
continued, and the patient has remained asymptomatic 
for eight months. 
 
Discussion 
 
This case shows the development of multiple compli-
cations in a patient that had a SES implanted including 
VLST, stent fracture, ISR, and a peri-stent aneurysm.   
ST is a rare but possibly lethal complication after im-
plantation of a DES. VLST by definition occurs more 
than one year after the procedure.
3) There are several 
mechanisms underlying the development of a ST. The 
most important factor is premature discontinuation of 
antiplatelet agents.
4) Other factors include LSM, delayed 
endothelialization, bifurcation lesions, renal failure, dia-
betes, and decreased systolic heart function.
4) Lately, the 
American Heart Association advisory board has recom-
mended continuation of dual antiplatelet therapy for 
12 months after DES placement.
5) In our patient, LSM, 
diabetes and a low ejection fraction were thought to be 
possible causes of the VLST.   
Stent fracture is another important potential compli-
cation after DES deployment, especially with an SES; it 
is a potential cause of ISR and ST elevation?
6)7) Stent frac-
ture has many possible causes, such as overexpansion of 
the stent struts, stent design, use of a long stent, overlap-
ping stents, hypermobile vessels, and tortuous vessels.
6)8) 
In this case, the exact causes of the delayed stent fracture 
were unknown. Two possible causes for the stent fracture 
are post-balloon dilatation therapy, which might have 
caused a strut microfracture, or a rigid and inflexible de-
sign of the SES, which occurs with a closed cell design 
and thick metal struts. However, post dilatation therapy 
is recommended to prevent stent under-expansion. 
ISR is a significant problem after stent implantation.   
A  B
Fig. 3. Coronary angiography demonstrates in-stent restenosis (white arrow) (A), while fluoroscopy shows a fractured sirolimus-eluting stent
(black arrow) (B). 
Fig. 4. A 64-slice multidetector computed tomogram shows an eccentric coronary aneurysm in the proximal left anterior descending artery
(black arrow) (A) and a cracked sirolimus-eluting stent (white arrow) (B). 
A  B 
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ISR usually occurs within six months after stent implan-
tation. The mechanism responsible for restenosis is as-
sociated with neointimal formation.
9) Additional risk 
factors for ISR include diabetes, lesion length, luminal 
cross-sectional area after stenting, the number and length 
of stents, and the plaque burden.
10-14) We found in a pre-
vious study that stent fracture may be another potential 
risk factor for ISR.
6) The patient reported here had dia-
betes, and stent under expansion was not observed after 
stent implantation. Because of the presence of focal ISR, 
involving the edge of the stent, as well as stent fracture, 
additional stent implantation was recommended. Cur-
rently, late catch-up has become a significant issue for the 
long-term effectiveness of DES. However, long-term an-
giographic studies are needed to study this issue further. 
The fourth complication was peri-stent aneurysm for-
mation. A coronary aneurysm is defined as a dilation of 
the coronary artery that exceeds 1.5 times the reference 
diameter of adjacent coronary segments that are angio-
graphically normal.
15) However, the incidence and precise 
mechanism of peri-stent aneurysms remain unknown. 
The delayed healing effects associated with LSM could 
have been associated with the development of an aneu-
rysm after DES implantation. LSM is defined as a sepa-
ration of one or more stent struts from the intima with 
no overlap with a side branch, and evidence of blood 
flow behind the strut. Possible explanations for an LSM 
include positive regional vascular remodeling, allergy to 
a drug, and late dissolution of a thrombus.
16)17) In our 
case, there were several possible causes of the aneurysm. 
First, the most likely cause of the aneurysm formation 
was LSM of the stent strut. Second, the delayed healing 
effects associated with rapamycin and patient-specific 
hypersensitivity were considered responsible for forma-
tion of the aneurysm. Third, late thrombus resolution 
may have occurred after the second primary percutane-
ous coronary intervention. There are no guidelines for 
the ideal treatment of patients that develop a coronary 
stent aneurysm. Our patient had no chest symptoms 
and the size of the coronary aneurysm was stable. For 
larger aneurysms surgical excision, percutaneous coiling, 
or the use of a covered stent might be considered.
18)19) 
In conclusion, the use of a DES has been associated 
with a number of complications. IVUS is essential for 
the planning of a therapeutic strategy. Additional angio-
graphic follow-up may be needed after stent placement. 
In the future, bioabsorbable polymer coated stents and 
more advanced stent platforms will be required to pre-
vent these serious complications. However, guidelines 
are now needed for the prevention and treatment of 
stent induced complications. 
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